Literature DB >> 25269597

Designing and modeling of complex DNA vaccine based on tropomyosin protein of Boophilus genus tick.

Mohamamd Mahdi Ranjbar1, Shishir K Gupta, Khodayar Ghorban, Sedigheh Nabian, Alireza Sazmand, Mohammad Taheri, Sahar Esfandyari, Maryam Taheri.   

Abstract

Boophilus tick is a bloodsucking ectoparasite that transfers some pathogens, reducing production and thus leading to economical losses in the cattle industry. Tropomyosin (TPM) protein is a salivary protein, has actin regulator activity, and plays an important role in immune reactions against parasites. In the current study, besides developing a safe, effective, and broad spectrum protective measure against Boophilus genus tick based on TPM protein, we attempted to minimize possible problems occurring in the design of polytopic vaccines. Briefly, the steps that were followed in the present study were as follows: retrieving sequences and finding the mutational/conservative regions, selecting consensus and high immunogenic epitopes of B and CD4(+) T cells by different approaches, three-dimensional structure (3D structure) prediction and representation of epitopes and highly variable/conserve regions, designing vaccinal construct by fusion of B and T cell epitopes by special patterns and improving immunogenicity, evaluation of the constructs' primary structure and posttranslational modification, calculation of hydrophobic regions, reverse translation, codon optimization, open reading frame checking, insertion of start/end codon, Kozak sequence, and finally constructing the DNA vaccine. Variation plot showed some shared epitopes among the ticks' and mites' species that some might be effective only in some species. Finally, by following the steps mentioned above, two constructs for B and T cells were achieved. Checking constructs revealed their reliability and efficacy for in vitro production and utilization. Successful in silico modeling is an essential step of designing vigorous vaccines. We developed a novel protective and therapeutic vaccine against Boophilus genus (based on TPM protein). At the next step, constructed DNA vaccine would be produced in vitro and administrated to cattle, and its potency to induction of immune response and protection against Boophilus genus as well as other ticks and mites will be evaluated.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25269597     DOI: 10.1007/s12010-014-1245-z

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  3 in total

1.  Identification and characterization of a cathepsin L-like cysteine protease from Rhipicephalus (Boophilus) annulatus.

Authors:  Shahin Saidi; Sedighe Nabian; Elahe Ebrahimzade; Ali Najafi; Mehrdad Moosazadeh Moghaddam; Alireza Sazmand; Masoud Torkzadeh-Mahani; Saeed Sattari Tabrizi
Journal:  Exp Appl Acarol       Date:  2015-11-23       Impact factor: 2.132

2.  Sequence-based approach for rapid identification of cross-clade CD8+ T-cell vaccine candidates from all high-risk HPV strains.

Authors:  Krishna P Singh; Neeraj Verma; Bashir A Akhoon; Vishal Bhatt; Shishir K Gupta; Shailendra K Gupta; Suchi Smita
Journal:  3 Biotech       Date:  2016-01-27       Impact factor: 2.406

3.  Introducing a new anti-Rhipicephalus (Boophilus) microplus tick recombinant vaccine candidate using cathepsin and tropomyosin multi-epitope gene.

Authors:  Zahra Asadollahi; Sedigheh Nabian; Mohammad Taheri; Elaheh Ebrahimzadeh
Journal:  Vet Res Forum       Date:  2021-12-15       Impact factor: 1.054

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.